Neuberger Berman Group
KITE

Neuberger Berman Group’s Kite Pharma, Inc. KITE Stock Holding History

Neuberger Berman Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,511
Closed -$364K – 1681
2017
Q2 		$364K Hold
3,511
– – ﹤0.01% 1376
2017
Q1 		$276K Buy
+3,511
New +$217K ﹤0.01% 1446
2016
Q3 		– Sell
-9,000
Closed -$450K – 1659
2016
Q2 		$450K Sell
9,000
-8,783
-49% -$432K ﹤0.01% 1265
2016
Q1 		$816K Buy
17,783
+4,681
+36% +$227K ﹤0.01% 1141
2015
Q4 		$807K Buy
+13,102
New +$922K ﹤0.01% 1171

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Neuberger Berman Group's KITE Position: Q3 2017 in Review

Neuberger Berman Group sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 3,511 shares — an estimated $364K sold.

Neuberger Berman Group first reported a position in KITE in Q4 2015 and held it in 5 quarters. The position peaked at $816K in Q1 2016. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Neuberger Berman Group reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Neuberger Berman Group sold 3,511 Kite Pharma, Inc. shares in Q3 2017, an estimated $364K.
  • Neuberger Berman Group first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 5 quarters.
  • Neuberger Berman Group's Kite Pharma, Inc. position peaked at $816K in Q1 2016.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Neuberger Berman Group's 13F filing for Q3 2017, filed 15 Nov 2017.